We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$15.4M
Cap. Flow
+$9.59M
Cap. Flow %
5.87%
Top 10 Hldgs %
57.69%
Holding
80
New
15
Increased
17
Reduced
17
Closed
15

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.45M
2
BIIB icon
Biogen
BIIB
+$1.36M
3
VIR icon
Vir Biotechnology
VIR
+$972K
4
BABA icon
Alibaba
BABA
+$611K
5
PRTA icon
Prothena Corp
PRTA
+$536K

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$3.37M
2
TPB icon
Turning Point Brands
TPB
+$1.83M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.82M
4
NFLX icon
Netflix
NFLX
+$1M
5
PYPL icon
PayPal
PYPL
+$499K

Sector Composition

Rank Sector Weight
1 Healthcare 39.59%
2 Technology 13.98%
3 Communication Services 7.11%
4 Consumer Discretionary 3.08%
5 Energy 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$1.64M 1.01%
40,250
+4,000
+11% +$173K
GM icon
27
General Motors
GM
$80.4B
$1.61M 0.99%
44,000
– –
VIR icon
28
Vir Biotechnology
VIR
$1.46B
$1.44M 0.88%
62,000
+38,000
+158% +$972K
BIIB icon
29
Biogen
BIIB
$30B
$1.36M 0.83%
+4,900
New +$1.36M
BABA icon
30
Alibaba
BABA
$293B
$1.29M 0.79%
12,600
+6,100
+94% +$611K
SLV icon
31
iShares Silver Trust
SLV
$28B
$1.11M 0.68%
50,000
-9,500
-16% -$197K
F icon
32
Ford
F
$58.5B
$1.07M 0.66%
85,000
– –
AMGN icon
33
CALL
Amgen
AMGN
$208B
$1.06M 0.65%
+4,400
New +$1.08M
CSCO icon
34
Cisco
CSCO
$457B
$1.05M 0.64%
20,000
– –
MRVL icon
35
Marvell Technology
MRVL
$168B
$974K 0.6%
22,500
+5,000
+29% +$211K
LNSR icon
36
LENSAR
LNSR
$61.5M
$873K 0.53%
350,742
+5,000
+1% +$14.2K
PAAS icon
37
Pan American Silver
PAAS
$18.2B
$819K 0.5%
45,000
+12,500
+38% +$215K
B
38
Barrick Mining
B
$61.5B
$743K 0.45%
40,000
+10,000
+33% +$180K
NOK icon
39
Nokia
NOK
$51B
$737K 0.45%
150,000
– –
STEW
40
SRH Total Return Fund
STEW
$1.79B
$725K 0.44%
59,000
– –
QCOM icon
41
Qualcomm
QCOM
$155B
$638K 0.39%
5,000
-2,500
-33% -$311K
MU icon
42
PUT
Micron Technology
MU
$930B
$603K 0.37%
+10,000
New +$586K
INTC icon
43
Intel
INTC
$455B
$572K 0.35%
+17,500
New +$496K
ALT icon
44
CALL
Altimmune
ALT
$552M
$565K 0.35%
134,000
-15,000
-10% -$178K
SNY icon
45
Sanofi
SNY
$103B
$539K 0.33%
9,900
-4,600
-32% -$224K
IMPL
46
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$536K 0.33%
383,148
+57,323
+18% +$137K
AMZN icon
47
Amazon
AMZN
$2.92T
$516K 0.32%
+5,000
New +$483K
EEM icon
48
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$493K 0.3%
+12,500
New +$497K
BUR icon
49
Burford Capital
BUR
$903M
$487K 0.3%
44,000
+9,000
+26% +$74.7K
BA icon
50
Boeing
BA
$171B
$478K 0.29%
+2,250
New +$467K
1
2
3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, DCF Advisers held 80 positions worth $163M, up 10% from $148M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

DCF Advisers deployed $9.59M of net new capital in Q1 2023, opening 15 new positions and adding to 17 existing holdings. Its largest new stake was Amgen: 10,000 shares worth $2.42M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bank of America, an estimated $3.37M trimmed.

  • DCF Advisers's largest Q1 2023 buy was Amgen: 10,000 shares worth $2.42M.
  • DCF Advisers added most to Vir Biotechnology in Q1 2023, an estimated $972K increase.
  • DCF Advisers's biggest Q1 2023 reduction was Bank of America, cutting an estimated $3.37M.
  • DCF Advisers fully exited Turning Point Brands in Q1 2023, selling an estimated $1.83M.
  • DCF Advisers's ten largest holdings make up 58% of its $163M portfolio in Q1 2023.
  • DCF Advisers opened 15 new positions and closed 15 in Q1 2023.
  • DCF Advisers's portfolio value rose 10% quarter-over-quarter to $163M.

Based on DCF Advisers's 13F filing for Q1 2023, filed 15 May 2023.